Home > Drug Search >
  • company_query: Aestus Therapeutics
  •   > 
Drug Filter
Category:
chemistry (59) biology (8)
Status:
Approved (6) NDA Filing (2) Phase Ⅲ (11) Phase Ⅱ (30) Phase Ⅰ (18)
Clinical Stage:
Pending (7) Active (34) Discontinued (20)
Bio-Type:
Vaccine (1) Whole antibody (2) Fusion protein (1)
Indication:
Acute bacterial skin and skin structure infections (ABSSSI) (3) Alcohol dependence (1) Alzheimer's disease (AD) (5) Anxiety (1) Aspergillosis (1) Asthma (2) Breast cancer (1) Cancer related pain (1) Candidiasis (1) Herpes zoster (1) Chemotherapy-induced peripheral neuropathy (1) Chronic lymphocytic leukemia (CLL) (1) Chronic pain (1) Cognitive disorders (2) Community-acquired pneumonia (CAP) (1) Constipation (1) Crohn's disease (1) Diarrhea (1) Dyslipidemia (1) Erectile dysfunction (ED) (1) Gastric ulcer (2) Gastrointestinal stromal tumors (GISTs) (1) HBV infection (1) HCV infection (4) Adult respiratory distress syndrome (ADRS) (1) HIV infection (1) Hyperuricemia (1) Inflammatory bowel disease (1) Leukemia (1) Lymphoma (1) Major depressive disorder (MDD) (2) Migraine (1) Multiple myeloma (MM) (1) Multiple sclerosis (MS) (1) Neuropathic pain (1) Non-Hodgkin’s lymphoma (NHL) (1) Osteoarthritis (OA) (1) Osteoporosis (1) Parkinson's disease (PD) (1) Peripheral T cell lymphoma (PTCL) (1) Postherpetic neuralgia (PHN) (2) Postoperative pain (1) Primary biliary cirrhosis (PBC) (1) Psoriatic arthritis (1) Rheumatoid arthritis (RA) (1) Schizophrenia (1) Solid tumours (8) Rotavirus infection (1) Ulcerative colitis (1) Uremic pruritus (1) Urinary incontinence (1) Head and neck cancer (2) Bone cancer (1) Hodgkin lymphoma (1) Colorectal cancer (1) Oesophageal varices (1) Pain (4) Acute pain (1) Diabetic foot infections of the skin and soft tissue (1) Acute Lung Injury (1) Hematological cancer (1) Spinal cord injury (1) Acromegaly (1) Gram-positive bacterial infection (1) Brain injury (1) Glioma (1) Neuroendocrine tumors (NET) (1) Plaque psoriasis (1) Basal cell nevus syndrome (1) Pulmonary fibrosis (1) Abdominal aortic aneurysm (1) Brain cancer (1) Muscle spasticity (1) Mild cognitive impairment(MCI) (1) Adrenocortical carcinoma (1) Renal failure (1) Neurological disease (1) Agitation in patients with Alzheimer's disease (1) plasmodium falciparum malaria (1) Dental pain (1)
Country:
US (1) JP (1) CN (1)
Aprv. Year:
2015 (1) 2016 (1) 2017 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 4 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top